Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil - comparison of outcomes from different static model types

Van Bellinghen, Laure-Anne; Marijam, Alen; de Araujo, Gabriela Tannus Branco; Gomez, Jorge; Van Vlaenderen, Ilse.
Braz. j. infect. dis ; 22(1): 1-10, Jan.-feb. 2018. tab
Artículo en Inglés | LILACS | ID: biblio-951627

Documentos relacionados

  1. Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil - comparison of outcomes from different static model types.
  2. [Economic evaluation on strategy for preventing mother-to-child transmission of hepatitis B in Zhejiang Province].
  3. The Potential Cost-Effectiveness of a Machine Learning Tool That Can Prevent Untimely Intensive Care Unit Discharge.
  4. Long-term cost-effectiveness of interventions for obesity: A mendelian randomisation study.
  5. Quantifying the direct secondary health care cost of seasonal influenza in England.
  6. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
  7. Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK: state of play and perspectives.
  8. Is Preoperative Type and Screen High-value Care? A Cost-effectiveness Analysis of Performing Preoperative Type and Screen Prior to Urogynecological Surgery.
  9. Hospital Capital Assets, Community Health, and the Utilization and Cost of Inpatient Care: A Population-Based Study of US Counties.
  10. Estimating a social cost of carbon for global energy consumption.